The Role of Electroconvulsive and Neuromodulation Therapies in the Treatment of Geriatric Depression

Psychiatric Clinics of North America

Volumn 36, Issue 4, 2013, Pages 607-630

  Riva Posse, Patricio ^a   Hermida, Adriana P ^a   McDonald, William M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electroconvulsive therapy; Geriatric depression; Neuromodulation; Treatment resistant depression

Indexed keywords

BENZODIAZEPINE; ETOMIDATE; FLUMAZENIL; KETAMINE; METHOHEXITAL; SUXAMETHONIUM;

ALZHEIMER DISEASE; BRAIN DEPTH STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DELIRIUM; DEPRESSION; DEPRESSIVE PSYCHOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DYSTONIA; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION THERAPY; ESSENTIAL TREMOR; FOCAL ELECTRICALLY ADMINISTERED SEIZURE THERAPY; GERIATRIC CARE; GERIATRIC PATIENT; HUMAN; LATE LIFE DEPRESSION; MAGNETIC SEIZURE THERAPY; MOOD DISORDER; NEUROLOGICAL AND SENSORIAL PROCEDURES; NEUROMODULATION; NEUROMONITORING; PARKINSON DISEASE; POSTSTROKE DEPRESSION; PRIORITY JOURNAL; REVIEW; SEIZURE; SEIZURE THRESHOLD; SEIZURE TITRATION; THERAPY EFFECT; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION;

ELECTROCONVULSIVE THERAPY; GERIATRIC DEPRESSION; NEUROMODULATION; TREATMENT-RESISTANT DEPRESSION;

AGE FACTORS; AGED; ANESTHESIA; COMORBIDITY; DEMENTIA; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; EVIDENCE-BASED PRACTICE; HUMANS; INFORMED CONSENT; PARKINSON DISEASE; STROKE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84887606345     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2013.08.007     Document Type: Review

References (213)

1. Unutzer J., Park M. Older adults with severe, treatment-resistant depression. JAMA 2012, 308(9):909-918.
2. Flint A.J. Treatment-resistant depression in late life. CNS Spectr 2002, 7(10):733-738.
3. Tew J.D., Mulsant B.H., Haskett R.F., et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999, 156(12):1865-1870.
4. Cattan R.A., Barry P.P., Mead G., et al. Electroconvulsive therapy in octogenarians. JAm Geriatr Soc 1990, 38(7):753-758.
5. Sackeim H.A., Prudic J., Fuller R., et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007, 32(1):244-254.
6. d'Elia G., Raotma H. Is unilateral ECT less effective than bilateral ECT?. Br J Psychiatry 1975, 126:83-89.
7. Letemendia F.J., Delva N.J., Rodenburg M., et al. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 1993, 23(2):349-360.
8. Swartz C.M. Asymmetric bilateral right frontotemporal left frontal stimulus electrode placement for electroconvulsive therapy. Neuropsychobiology 1994, 29(4):174-178.
9. Sackeim H.A., Prudic J., Devanand D.P., et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. NEngl J Med 1993, 328(12):839-846. [see comments].
10. Sackeim H.A., Prudic J., Devanand D.P., et al. Aprospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000, 57(5):425-434. [see comments].
11. Damm J., Eser D., Schule C., et al. Influence of age on effectiveness and tolerability of electroconvulsive therapy. JECT 2010, 26(4):282-288.
12. van der Wurff F.B., Stek M.L., Hoogendijk W.J., et al. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry 2003, 18(10):894-904.
13. Flint A.J., Gagnon N. Effective use of electroconvulsive therapy in late-life depression. Can J Psychiatry 2002, 47(8):734-741.
14. Greenberg R.M., Kellner C.H. Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry 2005, 13(4):268-281.
15. McCall W.V., Cohen W., Reboussin B., et al. Pretreatment differences in specific symptoms and quality of life among depressed inpatients who do and do not receive electroconvulsive therapy: a hypothesis regarding why the elderly are more likely to receive ECT. JECT 1999, 15(3):193-201.
16. Ladwig K.H., Klupsch D., Ruf E., et al. Sex- and age-related increase in prevalence rates of death wishes and suicidal ideation in the community: results from the KORA-F3 Augsburg Study with 3,154 men and women, 35 to 84 years of age. Psychiatry Res 2008, 161(2):248-252.
17. Conwell Y., Brent D. Suicide and aging. I: patterns of psychiatric diagnosis. Int Psychogeriatr 1995, 7(2):149-164.
18. Prudic J., Sackeim H.A. Electroconvulsive therapy and suicide risk. JClin Psychiatry 1999, 60(Suppl 2):104-110. [discussion: 111-6].
19. Kellner C.H., Fink M., Knapp R., et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 2005, 162(5):977-982.
20. Patel M., Patel S., Hardy D.W., et al. Should electroconvulsive therapy be an early consideration for suicidal patients?. JECT 2006, 22(2):113-115.
21. Brodaty H., Luscombe G., Parker G., et al. Increased rate of psychosis and psychomotor change in depression with age. Psychol Med 1997, 27(5):1205-1213.
22. Meyers B.S., Klimstra S.A., Gabriele M., et al. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 2001, 9(4):415-422.
23. Birkenhager T.K., Pluijms E.M., Lucius S.A. ECT response in delusional versus non-delusional depressed inpatients. JAffect Disord 2003, 74(2):191-195.
24. Petrides G., Fink M., Husain M.M., et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. JECT 2001, 17(4):244-253.
25. Aziz R., Lorberg B., Tampi R.R. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother 2006, 4(4):347-364.
26. Goldstein B.I., Herrmann N., Shulman K.I. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am J Psychiatry 2006, 163(2):319-321.
27. Rosenzweig I., Earl H., Wai C., et al. Geriatric manic delirium with no previous history of mania. JNeuropsychiatry Clin Neurosci 2011, 23(3):E39-E41.
28. Ciapparelli A., Dell'Osso L., Tundo A., et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. JClin Psychiatry 2001, 62(7):552-555.
29. Daly J.J., Prudic J., Devanand D.P., et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord 2001, 3(2):95-104.
30. Devanand D.P., Polanco P., Cruz R., et al. The efficacy of ECT in mixed affective states. JECT 2000, 16(1):32-37.
31. Husain M.M., Meyer D.E., Muttakin M.H., et al. Maintenance ECT for treatment of recurrent mania. Am J Psychiatry 1993, 150(6):985. [letter].
32. Keck P.E., Mendlwicz J., Calabrese J.R., et al. Areview of randomized, controlled clinical trials in acute mania. JAffect Disord 2000, 59(Suppl 1):S31-S37.
33. Kho K.H. Treatment of rapid cycling bipolar disorder in the acute and maintenance phase with ECT. JECT 2002, 18(3):159-161.
34. Macedo-Soares M.B., Moreno R.A., Rigonatti S.P., et al. Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. JECT 2005, 21(1):31-34.
35. Medda P., Perugi G., Zanello S., et al. Response to ECT in bipolar I, bipolar II and unipolar depression. JAffect Disord 2009, 118(1-3):55-59.
36. Medda P., Perugi G., Zanello S., et al. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. JECT 2010, 26(2):82-86.
37. Mukherjee S., Sackeim H.A., Schnur D.B. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994, 151(2):169-176. [see comments].
38. Poon S.H., Sim K., Sum M.Y., et al. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord 2012, 14(6):573-584.
39. Robinson L.A., Penzner J.B., Arkow S., et al. Electroconvulsive therapy for the treatment of refractory mania. JPsychiatr Pract 2011, 17(1):61-66.
40. Sachs G.S., Printz D.J., Kahn D.A., et al. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med 2000, (Spec No):1-104.
41. Sienaert P., Peuskens J. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord 2006, 8(3):304-306.
42. Sienaert P., Vansteelandt K., Demyttenaere K., et al. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord 2009, 11(4):418-424.
43. Tsao C.I., Jain S., Gibson R.H., et al. Maintenance ECT for recurrent medication-refractory mania. JECT 2004, 20(2):118-119.
44. Vaidya N.A., Mahableshwarkar A.R., Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. JECT 2003, 19(1):10-16.
45. Vanelle J.M., Loo H., Galinowski A., et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 1994, 10(3):195-205.
46. Vieta E., Colom F. Therapeutic options in treatment-resistant depression. Ann Med 2011, 43(7):512-530.
47. McDonald W.M., Nemeroff C.B. The diagnosis and treatment of mania in the elderly. Bull Menninger Clin 1996, 60(2):174-196.
48. McDonald W.M., Thompson T.R. Treatment of mania in dementia with electroconvulsive therapy. Psychopharmacol Bull 2001, 35(2):72-82.
49. Wilkins K.M., Ostroff R., Tampi R.R. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. JGeriatr Psychiatry Neurol 2008, 21(1):3-11.
50. McDonald W.M., Richard I.H., DeLong M.R. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003, 54(3):363-375.
51. Menza M., Dobkin R.D., Marin H. Treatment of depression in Parkinson's disease. Curr Psychiatry Rep 2006, 8(3):234-240.
52. McDonald W.M., Holtzheimer P.E., Byrd E.H. The diagnosis and treatment of depression in Parkinson's disease. Curr Treat Options Neurol 2006, 8(3):245-255.
53. Baez M.A., Avery J. Improvement in drug-induced parkinsonism with electroconvulsive therapy. Am J Geriatr Pharmacother 2011, 9(3):190-193.
54. Fregni F., Simon D.K., Wu A., et al. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. JNeurol Neurosurg Psychiatr 2005, 76(12):1614-1623.
55. Popeo D., Kellner C.H. ECT for Parkinson's disease. Med Hypotheses 2009, 73(4):468-469.
56. Aarsland D., Larsen J.P., Waage O., et al. Maintenance electroconvulsive therapy for Parkinson's disease. Convuls Ther 1997, 13(4):274-277.
57. McDonald W., Meeks T., McCall W., et al. Electroconvulsive therapy. Textbook of psychopharmacology 2009, 861-902. American Psychiatric Publishing, Washington, DC. 4th edition. A.F. Schatzberg, C.B. Nemeroff (Eds.).
58. Mulsant B.H., Rosen J., Thornton J.E., et al. Aprospective naturalistic study of electroconvulsive therapy in late-life depression. JGeriatr Psychiatry Neurol 1991, 4(1):3-13.
59. Hausner L., Damian M., Sartorius A., et al. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. JClin Psychiatry 2011, 72(1):91-97.
60. Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001, 9(4):361-381.
61. Ballard C., Gray A., Ayre G. Psychotic symptoms, aggression and restlessness in dementia. Rev Neurol (Paris) 1999, 155(Suppl 4):S44-S52.
62. Ballard C., Walker M. Neuropsychiatric aspects of Alzheimer's disease. Curr Psychiatry Rep 1999, 1(1):49-60.
63. Ballard C.G., Shaw F., Lowery K., et al. The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 1999, 10(2):97-103.
64. Bartels S.J., Horn S.D., Smout R.J., et al. Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use. Am J Geriatr Psychiatry 2003, 11(2):231-238.
65. Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. JECT 2012, 28(1):34-38.
66. Ujkaj M., Davidoff D.A., Seiner S.J., et al. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry 2012, 20(1):61-72.
67. Weintraub D., Hurtig H.I. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am J Psychiatry 2007, 164(10):1491-1498.
68. Takahashi S., Mizukami K., Yasuno F., et al. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy. Psychogeriatrics 2009, 9(2):56-61.
69. Rasmussen K.G., Russell J.C., Kung S., et al. Electroconvulsive therapy for patients with major depression and probable Lewy body dementia. JECT 2003, 19(2):103-109.
70. Hazzard W.R., Ettinger W.H. Aging and atherosclerosis: changing considerations in cardiovascular disease prevention as the barrier to immortality is approached in old age. Am J Geriatr Cardiol 1995, 4(4):16-36.
71. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37(2):577-617.
72. Lokk J., Delbari A. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat 2010, 6:539-549.
73. Hackett M.L., Anderson C.S., House A., et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008, (4). CD003437.
74. DeQuardo J.R., Tandon R. ECT in post-stroke major depression. Convuls Ther 1988, 4(3):221-224.
75. Murray G.B., Shea V., Conn D.K. Electroconvulsive therapy for poststroke depression. JClin Psychiatry 1986, 47(5):258-260.
76. Currier M.B., Murray G.B., Welch C.C. Electroconvulsive therapy for post-stroke depressed geriatric patients. JNeuropsychiatry Clin Neurosci 1992, 4(2):140-144.
77. Weintraub D., Lippmann S.B. Electroconvulsive therapy in the acute poststroke period. JECT 2000, 16(4):415-418.
78. Harmandayan M., Romanowicz M., Sola C. Successful use of ECT in post-stroke depression. Gen Hosp Psychiatry 2012, 34(1):102.e5-102.e6.
79. Miller A.R., Isenberg K.E. Reversible ischemic neurologic deficit after ECT. JECT 1998, 14(1):42-48.
80. Bruce B.B., Henry M.E., Greer D.M. Ischemic stroke after electroconvulsive therapy. JECT 2006, 22(2):150-152.
81. Weisberg L.A., Elliott D., Mielke D. Intracerebral hemorrhage following electroconvulsive therapy. Neurology 1991, 41(11):1849.
82. Pritchett J., Kellner C., Coffey C. Electroconvulsive therapy in geriatric neuropsychiatry. Textbook of geriatric neuropsychiatry 1994, 650-651. American Psychiatric Press, Washington, DC. C.E. Coffey, J.L. Cummings (Eds.).
83. Gazdag G., Takacs R., Ungvari G.S., et al. The practice of consenting to electroconvulsive therapy in the European Union. JECT 2012, 28(1):4-6.
84. Amazon J., McNeely E., Lehr S., et al. The decision making process of older adults who elect to receive ECT. JPsychosoc Nurs Ment Health Serv 2008, 46(5):45-52.
85. Brodaty H., Hickie I., Mason C., et al. Aprospective follow-up study of ECT outcome in older depressed patients. JAffect Disord 2000, 60(2):101-111.
86. Lapid M.I., Rummans T.A., Pankratz V.S., et al. Decisional capacity of depressed elderly to consent to electroconvulsive therapy. JGeriatr Psychiatry Neurol 2004, 17(1):42-46.
87. Chakrabarti S., Grover S., Rajagopal R. Perceptions and awareness of electroconvulsive therapy among patients and their families: a review of the research from developing countries. JECT 2010, 26(4):317-322.
88. Lapid M.I., Rummans T.A., Poole K.L., et al. Decisional capacity of severely depressed patients requiring electroconvulsive therapy. JECT 2003, 19(2):67-72.
89. Tang W.K., Ungvari G.S., Chan G.W. Patients' and their relatives' knowledge of, experience with, attitude toward, and satisfaction with electroconvulsive therapy in Hong Kong, China. JECT 2002, 18(4):207-212.
90. Task Force Report of the American Psychiatric Association The practice of electroconvulsive therapy: recommendations for treatment, training and privileging. Task force report on ECT 2001, American Psychiatric Association, Washington, DC. 2nd edition. R.D. Weiner (Ed.).
91. Akcaboy Z.N., Akcaboy E.Y., Yigitbasl B., et al. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol Scand 2005, 49(8):1068-1071.
92. Avramov M.N., Husain M.M., White P.F. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995, 81(3):596-602.
93. Badrinath S., Avramov M.N., Shadrick M., et al. The use of a ketamine-propofol combination during monitored anesthesia care. Anesth Analg 2000, 90(4):858-862.
94. Krystal A.D., Watts B.V., Weiner R.D., et al. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. JECT 1998, 14(1):5-14.
95. Gilabert E., Rojo E., Vallejo J. Augmentation of electroconvulsive therapy seizures with sleep deprivation. JECT 2004, 20(4):242-247.
96. Sawayama E., Takahashi M., Inoue A., et al. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy. JECT 2008, 24(3):195-198.
97. Cristancho M.A., Alici Y., Augoustides J.G., et al. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep 2008, 10(6):474-480.
98. Zielinski R.J., Roose S.P., Devanand D.P., et al. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993, 150(6):904-909.
99. Figiel G.S., McDonald W.M., McCall W.V., et al. Electroconvulsive therapy. Textbook of psychopharmacology 1995, 523-543. American Psychiatric Press, Washington, DC. A.F. Schatzberg, C.B. Nemeroff (Eds.).
100. Avramov M.N., Stool L.A., White P.F., et al. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy. JClin Anesth 1998, 10(5):394-400.
101. Zhang Y., White P.F., Thornton L., et al. The use of nicardipine for electroconvulsive therapy: a dose-ranging study. Anesth Analg 2005, 100(2):378-381.
102. Kokras N., Politis A.M., Zervas I.M., et al. Cardiac rhythm management devices and electroconvulsive therapy: a critical review apropos of a depressed patient with a pacemaker. JECT 2011, 27(3):214-220.
103. Dolenc T.J., Barnes R.D., Hayes D.L., et al. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004, 27(9):1257-1263.
104. Giltay E.J., Kho K.H., Keijzer L.T., et al. Electroconvulsive therapy (ECT) in a patient with a dual-chamber sensing, VDDR pacemaker. JECT 2005, 21(1):35-38.
105. Petrides G., Fink M. Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther 1996, 12(2):91-98.
106. Gardner M., Kellner M.D., Hood D., et al. The safe administration of ECT in a patient with a cardiac aneurysm and multiple cardiac risk factors. Convuls Ther 1997, 13(3):200-203.
107. Porquez J.M., Thompson T.R., McDonald W.M. Administration of ECT in a patient with an inoperable abdominal aortic aneurysm: serial imaging of the aorta during maintenance. JECT 2003, 19(2):118-120.
108. Pomeranze J., Karliner W., Triebel W.A., et al. Electroshock therapy in presence of serious organic disease. Depression and aortic aneurysm. Geriatrics 1968, 23(10):122-124.
109. Najjar F., Guttmacher L.B. ECT in the presence of intracranial aneurysm. JECT 1998, 14(4):266-271.
110. Boey W.K., Lai F.O. Comparison of propofol and thiopentone as anaesthetic agents for electroconvulsive therapy. Anaesthesia 1990, 45(8):623-628.
111. Rosa M.A., Rosa M.O., Belegarde I.M., et al. Recovery after ECT: comparison of propofol, etomidate and thiopental. Rev Bras Psiquiatr 2008, 30(2):149-151.
112. Hermida A, McClam T, Syre S, etal. Prevention of post-ictal agitation after electroconvulsive therapy. Poster session presented at the ISEN annual meeting. Philadelphia, May 7, 2012.
113. Sackeim H.A., Luber B., Moeller J.R., et al. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. JECT 2000, 16(2):110-120.
114. Deng Z.D., Lisanby S.H., Peterchev A.V. Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. JNeural Eng 2011, 8(1):016007.
115. Fujita A., Nakaaki S., Segawa K., et al. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. JECT 2006, 22(2):107-112.
116. Hyrman V. Pulse width and frequency in ECT. JECT 1999, 15(4):285-290.
117. Loo C.K., Sainsbury K., Sheehan P., et al. Acomparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT. Int J Neuropsychopharmacol 2008, 11(7):883-890.
118. Sackeim H.A., Prudic J., Nobler M.S., et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul 2008, 1(2):71-83.
119. Sienaert P., Vansteelandt K., Demyttenaere K., et al. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects. JAffect Disord 2010, 122(1-2):60-67.
120. Petrides G., Braga R.J., Fink M., et al. Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from CORE. JECT 2009, 25(4):232-237.
121. Coffey C.E., Lucke J., Weiner R.D., et al. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry 1995, 37(10):713-720.
122. McCall W.V., Reboussin D.M., Weiner R.D., et al. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 2000, 57(5):438-444. [see comments].
123. Quante A., Luborzewski A., Brakemeier E.L., et al. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. JPsychiatr Res 2011, 45(2):174-178.
124. Bennett D.M., Perrin J.S., Currie J., et al. Acomparison of ECT dosing methods using a clinical sample. JAffect Disord 2012, 141(2-3):222-226.
125. Petrides G., Braga R.J., Fink M., et al. Stimulus dosing in electroconvulsive therapy. JECT 2011, 27(3):268.
126. Prudic J., Sackeim H.A., Devanand D.P., et al. Acute cognitive effects of subconvulsive electrical stimulation. Convuls Ther 1994, 10(1):4-24.
127. Hermida A, Stair S, Zhao L, etal. Initial stimulus dosing in ECT: a comparison between seizure titration with other predictive dosing strategies. Poster session at the 2012 National Network of Depression Centers Conference. Rochester, November 8, 2012.
128. Figiel G.S., McDonald W.M., McCall W.V., et al. Electroconvulsive therapy. Textbook of psychopharmacology 1998, 523-524. American Psychiatric Press, Washington, DC. 2nd edition. A.F. Schatzberg, C.B. Nemeroff (Eds.).
129. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12(3):189-198.
130. Steif B.L., Sackeim H.A., Portnoy S., et al. Effects of depression and ECT on anterograde memory. Biol Psychiatry 1986, 21(10):921-930.
131. Prudic J., Peyser S., Sackeim H.A. Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. JECT 2000, 16(2):121-132. [see comments].
132. Lisanby S.H., Maddox J.H., Prudic J., et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000, 57(6):581-590.
133. Stoppe A., Louza M., Rosa M., et al. Fixed high-dose electroconvulsive therapy in the elderly with depression: a double-blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. JECT 2006, 22(2):92-99.
134. Kellner C.H., Knapp R., Husain M.M., et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010, 196(3):226-234.
135. Sobin C., Sackeim H.A., Prudic J., et al. Predictors of retrograde amnesia following ECT. Am J Psychiatry 1995, 152(7):995-1001.
136. Lerer B., Shapira B., Calev A., et al. Antidepressant and cognitive effects of twice- versus three-times-weekly ECT. Am J Psychiatry 1995, 152(4):564-570.
137. Krueger R.B., Sackeim H.A., Gamzu E.R. Pharmacological treatment of the cognitive side effects of ECT: a review. Psychopharmacol Bull 1992, 28(4):409-424.
138. Prudic J., Fitzsimons L., Nobler M.S., et al. Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology 1999, 21(2):285-293.
139. Prakash J., Kotwal A., Prabhu H. Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. JECT 2006, 22(3):163-168.
140. Matthews J.D., Blais M., Park L., et al. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study. JPsychiatr Res 2008, 42(7):526-531.
141. Kellner C.H., Knapp R.G., Petrides G., et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006, 63(12):1337-1344.
142. Rapinesi C., Kotzalidis G.D., Serata D., et al. Prevention of relapse with maintenance electroconvulsive therapy in elderly patients with major depressive episode. JECT 2013, 29(1):61-64.
143. Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?. JECT 2012, 28(1):39-47.
144. van Schaik A.M., Comijs H.C., Sonnenberg C.M., et al. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry 2012, 20(1):5-17.
145. Trevino K., McClintock S.M., Husain M.M. Areview of continuation electroconvulsive therapy: application, safety, and efficacy. JECT 2010, 26(3):186-195.
146. McDonald W.M., Phillips V.L., Figiel G.S., et al. Cost-effective maintenance treatment of resistant geriatric depression. Psychiatr Ann 1998, 28(1):47-52.
147. McDonald W.M. Is ECT cost-effective? A critique of the National Institute of Health and Clinical Excellence's report on the economic analysis of ECT. JECT 2006, 22(1):25-29.
148. Nordenskjold A., von Knorring L., Ljung T., et al. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial. JECT 2013, 29(2):86-92.
149. Nordenskjold A., von Knorring L., Engstrom I. Rehospitalization rate after continued electroconvulsive therapy-a retrospective chart review of patients with severe depression. Nord J Psychiatry 2011, 65(1):26-31.
150. Huuhka K., Viikki M., Tammentie T., et al. One-year follow-up after discontinuing maintenance electroconvulsive therapy. JECT 2012, 28(4):225-228.
151. Sackeim H.A., Haskett R.F., Mulsant B.H., et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001, 285(10):1299-1307. [see comments].
152. Tew J.D., Mulsant B.H., Haskett R.F., et al. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry 2007, 19(1):1-4.
153. Prudic J., Haskett R.F., McCall W.V., et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. JECT 2013, 29(1):3-12.
154. Sartorius A., Wolf J., Henn F.A. Lithium and ECT-concurrent use still demands attention: three case reports. World J Biol Psychiatry 2005, 6(2):121-124.
155. Small J.G., Kellams J.J., Milstein V., et al. Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry 1980, 15(1):103-112.
156. Small J.G., Milstein V. Lithium interactions: lithium and electroconvulsive therapy. JClin Psychopharmacol 1990, 10(5):346-350.
157. Weiner R.D., Whanger A.D., Erwin C.W., et al. Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. Am J Psychiatry 1980, 137(11):1452-1453.
158. Mukherjee S. Combined ECT and lithium therapy. Convuls Ther 1993, 9(4):274-284.
159. Stewart J.T. Lithium and maintenance ECT. JECT 2000, 16(3):300-301.
160. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. JNeuropsychiatry Clin Neurosci 1997, 9(3):471-481.
161. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003, 65:193-207.
162. Elger G., Hoppe C., Falkai P., et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000, 42(2-3):203-210.
163. Harden C.L., Pulver M.C., Ravdin L.D., et al. Apilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000, 1(2):93-99.
164. Dietrich D.E., Emrich H.M. The use of anticonvulsants to augment antidepressant medication. JClin Psychiatry 1998, 59(Suppl 5):51-58. [discussion: 59].
165. Krahl S.E., Senanayake S.S., Pekary A.E., et al. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. JPsychiatr Res 2004, 38(3):237-240.
166. George M.S., Sackeim H.A., Marangell L.B., et al. Vagus nerve stimulation. A potential therapy for resistant depression?. Psychiatr Clin North Am 2000, 23(4):757-783.
167. Rush A.J., Marangell L.B., Sackeim H.A., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58(5):347-354.
168. Rush A.J., Sackeim H.A., Marangell L.B., et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005, 58(5):355-363.
169. Sackeim H.A., Brannan S.K., Rush A.J., et al. Durability of antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol 2007, 10(6):817-826.
170. Sirven J.I., Sperling M., Naritoku D., et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology 2000, 54(5):1179-1182.
171. Merrill C.A., Jonsson M.A., Minthon L., et al. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. JClin Psychiatry 2006, 67(8):1171-1178.
172. O'Reardon J.P., Solvason H.B., Janicak P.G., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007, 62(11):1208-1216.
173. Schutter D.J. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med 2010, 40(11):1789-1795.
174. George M.S., Lisanby S.H., Avery D., et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010, 67(5):507-516.
175. Burt T., Lisanby S.H., Sackeim H.A. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002, 5(1):73-103.
176. Anderson B., Mishory A., Nahas Z., et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. JECT 2006, 22(1):49-53.
177. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998, 108(1):1-16.
178. Figiel G.S., Epstein C., McDonald W.M., et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J Neuropsychiatry Clin Neurosci 1998, 10(1):20-25.
179. Manes F., Jorge R., Morcuende M., et al. Acontrolled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr 2001, 13(2):225-231.
180. Jalenques I., Legrand G., Vaille-Perret E., et al. Therapeutic efficacy and safety of repetitive transcranial magnetic stimulation in depressions of the elderly: a review. Encephale 2010, 36(Suppl 2):D105-D118. [in French].
181. Lisanby S.H., Husain M.M., Rosenquist P.B., et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009, 34(2):522-534.
182. Toda H., Hamani C., Lozano A. Deep brain stimulation in the treatment of dyskinesia and dystonia. Neurosurg Focus 2004, 17(1):E2.
183. Benabid A.L., Pollak P., Louveau A., et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987, 50(1-6):344-346.
184. Lyons K.E., Pahwa R. Deep brain stimulation and essential tremor. JClin Neurophysiol 2004, 21(1):2-5.
185. Reclaim DBS therapy for OCD-H050003 2009, FDA, Maryland. Food and Drug Administration (Ed.).
186. Vitek J.L. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 2002, 17(Suppl 3):S69-S72.
187. Holtzheimer P.E., Kelley M.E., Gross R.E., et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012, 69(2):150-158.
188. Lozano A.M., Mayberg H.S., Giacobbe P., et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008, 64(6):461-467.
189. Kennedy S.H., Giacobbe P., Rizvi S.J., et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011, 168(5):502-510.
190. Puigdemont D., Perez-Egea R., Portella M.J., et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2011, 1-13.
191. Bewernick B.H., Hurlemann R., Matusch A., et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010, 67(2):110-116.
192. Bewernick B.H., Kayser S., Sturm V., et al. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012, 37(9):1975-1985.
193. Malone D.A., Dougherty D.D., Rezai A.R., et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009, 65(4):267-275.
194. Lozano A.M., Giacobbe P., Hamani C., et al. Amulticenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. JNeurosurg 2012, 116(2):315-322.
195. Riva-Posse P., Holtzheimer P.E., Garlow S.J., et al. Practical considerations in the development and refinement of subcallosal cingulate white matter deep brain stimulation for treatment resistant depression. World Neurosurg 2012, [Epub ahead of print]. 10.1016/j.wneu.2012.11.074.
196. Sartorius A., Kiening K.L., Kirsch P., et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010, 67(2):e9-e11.
197. Jimenez F., Velasco F., Salin-Pascual R., et al. Apatient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005, 57(3):585-593. [discussion: 585-93].
198. Coenen V.A., Schlaepfer T.E., Maedler B., et al. Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 2011, 35(9):1971-1981.
199. Blomstedt P., Sjoberg R.L., Hansson M., et al. Deep brain stimulation in the treatment of depression. Acta Psychiatr Scand 2011, 123(1):4-11.
200. Laxton A.W., Lozano A.M. Deep brain stimulation for the treatment of Alzheimer disease and dementias. World Neurosurg 2012, [Epub ahead of print]. 10.1016/j.wneu.2012.06.028.
201. Laxton A.W., Tang-Wai D.F., McAndrews M.P., et al. Aphase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 2010, 68(4):521-534.
202. Moreines J.L., McClintock S.M., Holtzheimer P.E. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul 2011, 4(1):17-27.
203. Grubert C., Hurlemann R., Bewernick B.H., et al. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 2011, 12(7):516-527.
204. Fritsch B., Reis J., Martinowich K., et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 2010, 66(2):198-204.
205. Fregni F., Boggio P.S., Nitsche M.A., et al. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006, 8(2):203-204.
206. Boggio P.S., Rigonatti S.P., Ribeiro R.B., et al. Arandomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008, 11(2):249-254.
207. Loo C.K., Sachdev P., Martin D., et al. Adouble-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 2010, 13(1):61-69.
208. Dell'Osso B., Priori A., Altamura A.C. Efficacy and safety of transcranial direct current stimulation in major depression. Biol Psychiatry 2011, 69(8):e23-e24.
209. Minhas P., Bansal V., Patel J., et al. Electrodes for high-definition transcutaneous DC stimulation for applications in drug delivery and electrotherapy, including tDCS. JNeurosci Methods 2010, 190(2):188-197.
210. Lisanby S.H., Luber B., Schlaepfer T.E., et al. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003, 28(10):1852-1865.
211. Kayser S., Bewernick B., Axmacher N., et al. Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder. JECT 2009, 25(2):137-140.
212. Spellman T., Peterchev A.V., Lisanby S.H. Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology 2009, 34(8):2002-2010.
213. Nahas Z. Focal Electroconvulsive Therapy for Depression (FEAST). 2012. Available at: Accessed December 15, 2012. http://clinicaltrials.gov/.